Morgan Stanley
MLSS icon

Morgan Stanley’s Milestone Scientific MLSS Stock Holding History

Morgan Stanley’s Portfolio MLSS Stock Details MLSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$967 Sell
3,011
-2,500
-45% -$859 ﹤0.01% 7517
2026
Q1 		$1.59K Hold
5,511
– – ﹤0.01% 7368
2025
Q4 		$1.5K Sell
5,511
-5,000
-48% -$1.9K ﹤0.01% 7297
2025
Q3 		$4.78K Buy
10,511
+4,999
+91% +$2.92K ﹤0.01% 7100
2025
Q2 		$3.51K Hold
5,512
– – ﹤0.01% 7121
2025
Q1 		$5.14K Buy
5,512
+1,401
+34% +$1.54K ﹤0.01% 6984
2024
Q4 		$3.95K Buy
4,111
+361
+10% +$298 ﹤0.01% 7069
2024
Q3 		$3.41K Sell
3,750
-100
-3% -$94 ﹤0.01% 7010
2024
Q2 		$2.63K Sell
3,850
-3,734
-49% -$2.48K ﹤0.01% 7018
2024
Q1 		$4.72K Hold
7,584
– – ﹤0.01% 6901
2023
Q4 		$5.23K Sell
7,584
-3,753
-33% -$2.99K ﹤0.01% 6826
2023
Q3 		$10.4K Sell
11,337
-4,013
-26% -$4.23K ﹤0.01% 6722
2023
Q2 		$13.4K Buy
15,350
+100
+0.7% +$90 ﹤0.01% 6703
2023
Q1 		$13.7K Buy
15,250
+3,899
+34% +$2.85K ﹤0.01% 6767
2022
Q4 		$5.45K Sell
11,351
-1,000
-8% -$647 ﹤0.01% 7124
2022
Q3 		$10K Hold
12,351
– – ﹤0.01% 7067
2022
Q2 		$11K Sell
12,351
-66,379
-84% -$67.7K ﹤0.01% 7186
2022
Q1 		$119K Sell
78,730
-135,410
-63% -$198K ﹤0.01% 6216
2021
Q4 		$441K Sell
214,140
-199,200
-48% -$438K ﹤0.01% 5616
2021
Q3 		$773K Sell
413,340
-361,154
-47% -$668K ﹤0.01% 5222
2021
Q2 		$1.9M Buy
774,494
+734,883
+1,855% +$1.78M ﹤0.01% 4674
2021
Q1 		$142K Buy
39,611
+3,062
+8% +$10.5K ﹤0.01% 5843
2020
Q4 		$77K Buy
36,549
+31,846
+677% +$56.1K ﹤0.01% 6019
2020
Q3 		$6K Sell
4,703
-7,135
-60% -$12.4K ﹤0.01% 6410
2020
Q2 		$23K Buy
11,838
+10,838
+1,084% +$19.8K ﹤0.01% 5972
2020
Q1 		$1K Buy
+1,000
New +$1.8K ﹤0.01% 6469
2018
Q3 		– Sell
-60
Closed – – 6760
2018
Q2 		$0 Buy
+60
New +$47 ﹤0.01% 6715

Other funds holding MLSS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $4.99B AUM 23.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Morgan Stanley's MLSS Position: Q2 2026 in Review

Morgan Stanley reduced its Milestone Scientific (MLSS) stake by 45% in Q2 2026, selling an estimated $859 and leaving 3,011 shares worth $967. The position accounts for ﹤0.01% of the portfolio, ranked #7517.

Morgan Stanley first reported a position in MLSS in Q2 2018 and has held it in 27 quarters since. The position peaked at $1.9M in Q2 2021. 29 funds tracked by Wall St. Rank hold MLSS as of Q2 2026.

  • Morgan Stanley held 3,011 shares of Milestone Scientific worth $967 as of Q2 2026.
  • Morgan Stanley sold 2,500 Milestone Scientific shares in Q2 2026, an estimated $859.
  • Milestone Scientific made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7517 holding.
  • Morgan Stanley first reported a position in Milestone Scientific in Q2 2018 and has held it in 27 quarters since.
  • Morgan Stanley's Milestone Scientific position peaked at $1.9M in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.